Neira J
Subcell Biochem. 2024; 105:171-206.
PMID: 39738947
DOI: 10.1007/978-3-031-65187-8_5.
Gruenke P, Mayer M, Aneja R, Schulze W, Song Z, Burke D
ACS Infect Dis. 2024; 10(8):2637-2655.
PMID: 39016538
PMC: 11320578.
DOI: 10.1021/acsinfecdis.3c00708.
Dick A, Meuser M, Cocklin S
Biomolecules. 2022; 12(5).
PMID: 35625621
PMC: 9138599.
DOI: 10.3390/biom12050695.
Gruenke P, Aneja R, Welbourn S, Ukah O, Sarafianos S, Burke D
Nucleic Acids Res. 2022; 50(3):1701-1717.
PMID: 35018437
PMC: 8860611.
DOI: 10.1093/nar/gkab1293.
Manoto S, El-Hussein A, Malabi R, Thobakgale L, Ombinda-Lemboumba S, Attia Y
Saudi J Biol Sci. 2020; 28(1):78-89.
PMID: 32868971
PMC: 7449958.
DOI: 10.1016/j.sjbs.2020.08.034.
Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities.
Sun L, Huang T, Dick A, Meuser M, Zalloum W, Chen C
Eur J Med Chem. 2020; 190:112085.
PMID: 32066010
PMC: 7053825.
DOI: 10.1016/j.ejmech.2020.112085.
HIV-1 Virus Interactions With Host Proteins: Interaction of the N-terminal Domain of the HIV-1 Capsid Protein With Human Calmodulin.
Tzou Y, Shin R, Krishna N
Nat Prod Commun. 2019; 14(5).
PMID: 31388391
PMC: 6684243.
DOI: 10.1177/1934578X19849190.
Contributions of Charged Residues in Structurally Dynamic Capsid Surface Loops to Rous Sarcoma Virus Assembly.
Heyrana K, Goh B, Perilla J, Nguyen T, England M, Bewley M
J Virol. 2016; 90(12):5700-5714.
PMID: 27053549
PMC: 4886791.
DOI: 10.1128/JVI.00378-16.
Proteomics, biomarkers, and HIV-1: A current perspective.
Donnelly M, Ciborowski P
Proteomics Clin Appl. 2015; 10(2):110-25.
PMID: 26033875
PMC: 4666820.
DOI: 10.1002/prca.201500002.
Human immunodeficiency virus type 1 employs the cellular dynein light chain 1 protein for reverse transcription through interaction with its integrase protein.
Jayappa K, Ao Z, Wang X, Mouland A, Shekhar S, Yang X
J Virol. 2015; 89(7):3497-511.
PMID: 25568209
PMC: 4403391.
DOI: 10.1128/JVI.03347-14.
Production and purification of polymerization-competent HIV-1 capsid protein p24 (CA) in NiCo21(DE3) Escherichia coli.
Teow S, Mualif S, Omar T, Wei C, Mohd Yusoff N, Ali S
BMC Biotechnol. 2013; 13:107.
PMID: 24304876
PMC: 4235032.
DOI: 10.1186/1472-6750-13-107.
Immunization against small ruminant lentiviruses.
Reina R, de Andres D, Amorena B
Viruses. 2013; 5(8):1948-63.
PMID: 23917352
PMC: 3761235.
DOI: 10.3390/v5081948.
Cyclophilin A-dependent restriction to capsid N121K mutant human immunodeficiency virus type 1 in a broad range of cell lines.
Takemura T, Kawamata M, Urabe M, Murakami T
J Virol. 2013; 87(7):4086-90.
PMID: 23325683
PMC: 3624240.
DOI: 10.1128/JVI.01319-12.
Dual role for motif 1 residues of human lysyl-tRNA synthetase in dimerization and packaging into HIV-1.
Dewan V, Wei M, Kleiman L, Musier-Forsyth K
J Biol Chem. 2012; 287(50):41955-62.
PMID: 23095741
PMC: 3516742.
DOI: 10.1074/jbc.M112.421842.
Functional constraints on HIV-1 capsid: their impacts on the viral immune escape potency.
Takemura T, Murakami T
Front Microbiol. 2012; 3:369.
PMID: 23087682
PMC: 3474374.
DOI: 10.3389/fmicb.2012.00369.
Proteomic analysis of HIV-T cell interaction: an update.
Kramer G, Moerland P, Jeeninga R, Vlietstra W, Ringrose J, Byrman C
Front Microbiol. 2012; 3:240.
PMID: 22783244
PMC: 3389432.
DOI: 10.3389/fmicb.2012.00240.
Deployment of the human immunodeficiency virus type 1 protein arsenal: combating the host to enhance viral transcription and providing targets for therapeutic development.
Dahiya S, Nonnemacher M, Wigdahl B
J Gen Virol. 2012; 93(Pt 6):1151-1172.
PMID: 22422068
PMC: 3755519.
DOI: 10.1099/vir.0.041186-0.
Cyclic peptide inhibitors of HIV-1 capsid-human lysyl-tRNA synthetase interaction.
Dewan V, Liu T, Chen K, Qian Z, Xiao Y, Kleiman L
ACS Chem Biol. 2012; 7(4):761-9.
PMID: 22276994
PMC: 3330833.
DOI: 10.1021/cb200450w.
Structure of a monomeric mutant of the HIV-1 capsid protein.
Shin R, Tzou Y, Krishna N
Biochemistry. 2011; 50(44):9457-67.
PMID: 21995733
PMC: 3210698.
DOI: 10.1021/bi2011493.
Rationally designed interfacial peptides are efficient in vitro inhibitors of HIV-1 capsid assembly with antiviral activity.
Bocanegra R, Nevot M, Domenech R, Lopez I, Abian O, Rodriguez-Huete A
PLoS One. 2011; 6(9):e23877.
PMID: 21931621
PMC: 3169566.
DOI: 10.1371/journal.pone.0023877.